City of Hope develops cell therapy for ovarian cancer
City of Hope researchers are developing a chimeric antigen receptor (CAR) T cell therapy for the treatment of recurrent ovarian cancer.
City of Hope researchers are developing a chimeric antigen receptor (CAR) T cell therapy for the treatment of recurrent ovarian cancer.
What's Your Reaction?
